EYESTEM

eyestem-logo

Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treat incurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety.

#People #Financial #Event #Website #More

EYESTEM

Social Links:

Industry:
Biotechnology

Founded:
2016-01-01

Address:
Bengaluru, Karnataka, India

Country:
India

Website Url:
http://www.eyestem.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
6.41 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Current Employees Featured

rajani-battu_image

Rajani Battu
Rajani Battu Co-Founder & CMO @ Eyestem
Co-Founder & CMO

dr-jogin-desai_image

Dr. Jogin Desai
Dr. Jogin Desai Founder & Chief Executive Officer @ Eyestem
Founder & Chief Executive Officer
2016-07-01

jogin-desai_image

Jogin Desai
Jogin Desai Founder and CEO @ Eyestem
Founder and CEO
2016-07-01

Founder


dr-jogin-desai_image

Dr. Jogin Desai

jogin-desai_image

Jogin Desai

rajani-battu_image

Rajani Battu

Investors List

natco-pharma_image

Natco Pharma

Natco Pharma investment in Series A - Eyestem

kotak-private-equity-adfb_image

Kotak Private Equity

Kotak Private Equity investment in Series A - Eyestem

biological-e_image

Biological E.

Biological E. investment in Series A - Eyestem

alkem-laboratories_image

Alkem Laboratories

Alkem Laboratories investment in Series A - Eyestem

karan-bagaria_image

Karan Bagaria

Karan Bagaria investment in Series A - Eyestem

anurag-bagaria_image

Anurag Bagaria

Anurag Bagaria investment in Series A - Eyestem

endiya-partners_image

Endiya Partners

Endiya Partners investment in Series A - Eyestem

endiya-partners_image

Endiya Partners

Endiya Partners investment in Seed Round - Eyestem

church-street-trustees_image

Church Street Trustees

Church Street Trustees investment in Seed Round - Eyestem

gillian-corken_image

Gillian Corken

Gillian Corken investment in Seed Round - Eyestem

Newest Events participated

16th-nasscom-product-conclave-2019_event_image Participated in 16th NASSCOM Product Conclave 2019 on 2019-11-05 as speaker

Official Site Inspections

http://www.eyestem.com

  • Host name: 26.137.66.148.host.secureserver.net
  • IP address: 148.66.137.26
  • Location: Singapore
  • Latitude: 1.3667
  • Longitude: 103.8
  • Timezone: Asia/Singapore

Loading ...

More informations about "Eyestem"

Eyestem - Crunchbase Company Profile & Funding

Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also โ€ฆSee details»

Eyestem Senior Management and Advisors | Eyestem

At Eyestem, she is involved in the development of iPSC-derived Retinal Pigment Epithelium (RPE) for the treatment of dry-AMD. Mamatha Jayagopal Senior Manager, Finance. Mamatha did her Masters in Finance from Annamalai โ€ฆSee details»

Eyestem - 2025 Company Profile, Funding

Mar 28, 2025 Eyestem is a series A company based in Bengaluru (India), founded in 2015 by Jogin Bhairav Desai, Rajani Ravindra Battu, Dhruv Sareen and Rajarshi Pal. It operates as a Developer of scalable cell replacement โ€ฆSee details»

Our Product Pipeline | Eyestem

Our Lead Asset. Eyecyte-RPE TM replaces lost retinal pigment epithelium cells. It is designed to restore sight for patients in the early stages of Age-Related Macular Degeneration and arrest losses for those in the later stages.See details»

Eyestem 2025 Company Profile: Valuation, Funding

Eyestem General Information Description. Developer of scalable cell replacement therapies designed to treat incurable diseases. The company's platform aims to replace damaged photoreceptor cells in the eye with healthy, transplantable โ€ฆSee details»

Eyestem - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Endiya Partners: Jul 25, โ€ฆSee details»

Eyestem Company Profile Funding & Investors

Eyestem is an innovative Bangalore based startup incubated at the Centre for Cellular and Molecular Platforms - a premier biotech incubator in the country. Dr. Jogin Desai, founder and CEO, was ...See details»

Eyestem - Contacts, Employees, Board Members, Advisors & Alumni

Eyestem is a cell therapy company founded by a top-class management team. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by AI . Experience the new โ€ฆSee details»

Eyestem is a trailblazing cell therapy company

Eyestem is a trailblazing cell therapy company led by a top-tier management team of clinical trials, cell therapy, and ophthalmology experts. Supported by a world-class advisory board and collaborations with industry pioneers, Eyestem โ€ฆSee details»

Eyestem - Products, Competitors, Financials, Employees, โ€ฆ

Eyestem to Start Human Trials for Its Pioneering Dry AMD Treatment. Apr 3, 2024. atment 03rd April 2024: Eyestem, a cell therapy company at the forefront of regenerative therapy, has โ€ฆSee details»

Eyestem Pioneers Scalable Cell Replacement Therapies for Global โ€ฆ

Sep 10, 2024 Eyestem is revolutionizing global healthcare by developing scalable, affordable cell replacement therapies for incurable diseases like AMD, RP, and IPFSee details»

Eyestem files for CDSCO approval for Eyecyte-RPE

Eyecyte-RPE will be used to treat geographic atrophy Eyestem Research announced the submission of an Investigational New Drug (IND) application to the Central Drugs Standards โ€ฆSee details»

Our Technology | Eyestem

About Us Our Technology . https://www.youtube.com/watch?v=z2OH4fGsY4M. About Us; Science; Publications; Collaborations; UpdatesSee details»

Eyestem completes first round of patient injections for its dry AMD ...

Aug 20, 2024 Eyestem Research Private Ltd hopes to shift the paradigm of ophthalmology in India with the completion of the first set of 3 patient injections for its RPE suspension therapy โ€ฆSee details»

#startupoftheday 153- Eyestem Research - BioSpectrum India

Eyestem intends to be the benchmark for quality and affordability in cells therapies for targeted conditions and expects to capture 1/6th of the global market. Have patents in India and the US โ€ฆSee details»

Eyestem: A Vision For The Future - Forbes India

Oct 11, 2023 The first product Eyestem is developing is to treat a condition called dry age-related macular degeneration, the largest cause of incurable blindness for people over 50 in โ€ฆSee details»

Eyestem - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Mar 10, 2025 Organization. Eyestem . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. Monthly โ€ฆSee details»

Eyestemโ€™s Eyecyte-RPEโ„ข Trial Shows Vision Rescue for

6 days ago Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10 th Retinal Cell and Gene Therapy Innovation Summit in early May. For more information, โ€ฆSee details»

What's happening at Eyestem | Eyestem

National, (Date) - Eyestem, a cell therapy company at the forefront of regenerative therapy, has received approval from Indiaโ€™s Central Drugs Standards Control Organisation (CDSCO) to โ€ฆSee details»

India-based Eyestem receives approval to commence human trial โ€ฆ

Apr 14, 2024 Eyestemโ€™s Eyecyte RPE therapy aims to replace lost or damaged Retinal Pigment Epithelium (RPE) cells, which is a shift in tackling the disease. The goal is to preserve and โ€ฆSee details»